Sarah Jean Gowing

Cambridge Broadband Networks Ltd. provides wireless backhaul and access solutions. The firm offers network planning and design, network deployment, network operation, training, and customer support services. The company was founded by John Naylon, Damian P. Gilmurray, Alistair John Massarella, John David Porter, Stephen David Greaves, Andrew Hopper, David Pegler, Oliver Mason, Peter Ross Wharton and Melvyn Noakes on November 11th 1999 and is headquartered in Cambridge, the United Kingdom.

Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.

Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom.